Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
tenofovir + emtricitabine + abacavir
- Development stage
- Unknown
- Lead developer
- Salud Pharma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
tenofovir + emtricitabine + abacavir is a fixed-dose combination of three antiretroviral agents used for the treatment of HIV-1 infection. The combination includes tenofovir (a nucleotide reverse transcriptase inhibitor, NtRTI), emtricitabine (a nucleoside reverse transcriptase inhibitor, NRTI), and abacavir (a nucleoside reverse transcriptase inhibitor, NRTI). These drugs work by inhibiting the HIV-1 reverse transcriptase enzyme, which is responsible for converting viral RNA into DNA. By acting as chain terminators and competing with natural deoxynucleotides for incorporation into viral DNA, they prevent the elongation of the viral DNA strand, thereby halting viral replication. This product is distributed by Salud Pharma as part of its portfolio of generic specialized medications in Panama.
- Other names
- Triple NRTI/NtRTI combination
02
Targets
Human immunodeficiency virus type 1 reverse transcriptase
Beyond the preview
Go deeper on tenofovir + emtricitabine + abacavir.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on tenofovir + emtricitabine + abacavir.